Skip to main content

TransGlobal Assets Inc. (TMSH)

OTC Markets (US) Healthcare Drug Manufacturers - Specialty & GenericView data quality →
29.1Poor

ValueMarkers Composite Index

Top 0%#44,640 of 44,707

DCF data not available

Piotroski
1/9
Weak
Beneish
-
Altman
-3.90
Distress
DCF Value
-
N/A
ROIC
-44.8%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

TransGlobal Assets Inc. (TMSH) — VMCI valuation read

TransGlobal Assets Inc. sits at VMCI 29/100, with the Healthcare sector median at 50. That 21-point spread is the first thing to note on TMSH: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on TMSH are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on TMSH: TMSH trades at 24.0x earnings, 33% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of 3.5x is the binding constraint on the bear case, anchoring the bear scenario on a measurable balance-sheet metric.

TMSH fell 3.4% over the trailing 7 days, with a -14.4% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in TMSH’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.